Indication for aldosterone antagonist after STMI:
a) Left ventricular ejection fraction (LVEF) ≤ 40%
b) Heart failure symptoms despite optimal medical therapy
c) Post-MI with symptomatic heart failure and reduced ejection fraction
d) All of the above